SEK 37.26
(3.33%)
Year | Inventory | Inventory Growth |
---|---|---|
2022 | 493.1 Million SEK | 53.81% |
2021 | 320.6 Million SEK | 671.34% |
2020 | 41.56 Million SEK | 44.94% |
2019 | 28.67 Million SEK | 614.78% |
2018 | 4.01 Million SEK | 73.3% |
2017 | 2.31 Million SEK | 561.43% |
2016 | 350 Thousand SEK | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 Q3 | 505.3 Million SEK | -8.03% |
2023 Q1 | 546.3 Million SEK | 10.79% |
2023 Q2 | 549.4 Million SEK | 0.57% |
2022 Q1 | 416.5 Million SEK | 29.91% |
2022 Q4 | 493.1 Million SEK | -11.46% |
2022 Q3 | 556.9 Million SEK | 13.75% |
2022 Q2 | 489.6 Million SEK | 17.55% |
2022 FY | 493.1 Million SEK | 53.81% |
2021 Q4 | 320.6 Million SEK | 15.2% |
2021 Q1 | 148.4 Million SEK | 0.0% |
2021 FY | 320.6 Million SEK | 671.34% |
2021 Q2 | 224.4 Million SEK | 51.21% |
2021 Q3 | 278.3 Million SEK | 24.02% |
2020 FY | 41.56 Million SEK | 44.94% |
2020 Q3 | 41.56 Million SEK | -4.73% |
2020 Q1 | 35.78 Million SEK | 6.29% |
2020 Q2 | 43.62 Million SEK | 21.91% |
2019 Q2 | 11.24 Million SEK | 43.26% |
2019 Q1 | 7.85 Million SEK | 63.37% |
2019 Q3 | 28.67 Million SEK | 155.0% |
2019 FY | 28.67 Million SEK | 614.78% |
2019 Q4 | 33.67 Million SEK | 17.41% |
2018 Q2 | 3.6 Million SEK | -2.14% |
2018 FY | 4.01 Million SEK | 73.3% |
2018 Q4 | 4.8 Million SEK | 19.77% |
2018 Q3 | 4.01 Million SEK | 11.26% |
2018 Q1 | 3.68 Million SEK | 14.76% |
2017 Q2 | 900 Thousand SEK | 53.85% |
2017 Q4 | 3.21 Million SEK | 38.7% |
2017 FY | 2.31 Million SEK | 561.43% |
2017 Q1 | 585 Thousand SEK | 26.02% |
2017 Q3 | 2.31 Million SEK | 157.22% |
2016 FY | 350 Thousand SEK | 0.0% |
2016 Q4 | 464.2 Thousand SEK | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Acarix AB (publ) | 6.83 Million SEK | -7110.118% |
ADDvise Group AB (publ) | 121.2 Million SEK | -306.848% |
ADDvise Group AB (publ) | 121.2 Million SEK | -306.848% |
Arcoma AB | 28.02 Million SEK | -1659.375% |
Bactiguard Holding AB (publ) | 29.64 Million SEK | -1563.294% |
Boule Diagnostics AB (publ) | 62.4 Million SEK | -690.224% |
CellaVision AB (publ) | 126.03 Million SEK | -291.231% |
Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -7963.778% |
Chordate Medical Holding AB (publ) | 1.77 Million SEK | -27744.269% |
C-Rad AB (publ) | 64.09 Million SEK | -669.267% |
Duearity AB (publ) | 4.15 Million SEK | -11756.215% |
Dignitana AB (publ) | 7.41 Million SEK | -6551.828% |
Episurf Medical AB (publ) | 3.7 Million SEK | -13227.027% |
Getinge AB (publ) | 6.41 Billion SEK | 92.315% |
Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 29392.414% |
Iconovo AB (publ) | -4.86 Million SEK | 10241.917% |
Integrum AB (publ) | 22.36 Million SEK | -2105.085% |
Luxbright AB (publ) | 8000.00 SEK | -6163650.0% |
Mentice AB (publ) | 14.1 Million SEK | -3396.171% |
OssDsign AB (publ) | 4.3 Million SEK | -11356.784% |
Paxman AB (publ) | 19.99 Million SEK | -2365.623% |
Promimic AB (publ) | 330 Thousand SEK | -149324.242% |
Qlife Holding AB (publ) | 7.29 Million SEK | -6662.205% |
SciBase Holding AB (publ) | 11.91 Million SEK | -4037.092% |
ScandiDos AB (publ) | 22.69 Million SEK | -2073.204% |
Sectra AB (publ) | 36.59 Million SEK | -1247.636% |
Sedana Medical AB (publ) | 42.97 Million SEK | -1047.411% |
Senzime AB (publ) | 20.34 Million SEK | -2324.287% |
SpectraCure AB (publ) | 1.00 SEK | -49309999900.0% |
Stille AB | 66.55 Million SEK | -640.913% |
Vitrolife AB (publ) | 413 Million SEK | -19.395% |
Xvivo Perfusion AB (publ) | 141.6 Million SEK | -248.225% |